Sabine Yerly mostly deals with Virology, Internal medicine, Immunology, Drug resistance and Viral disease. The various areas that Sabine Yerly examines in her Virology study include Reverse transcriptase and Epidemiology. Sabine Yerly has included themes like Surgery, Gastroenterology, Reverse-transcriptase inhibitor, Placebo and Ritonavir in her Internal medicine study.
Sabine Yerly has researched Immunology in several fields, including Bronchoalveolar lavage, Lung, Prospective cohort study and Respiratory system. Her Drug resistance research incorporates themes from Protease inhibitor and HIV drug resistance. Her specific area of interest is Viral disease, where Sabine Yerly studies Sida.
Her primary areas of study are Virology, Immunology, Internal medicine, Viral load and Drug resistance. Her Virus, Lentivirus, Sida, Viral disease and Zidovudine study are her primary interests in Virology. Her Viral disease study integrates concerns from other disciplines, such as Acquired immunodeficiency syndrome and Immunopathology.
She works mostly in the field of Immunology, limiting it down to topics relating to Transmission and, in certain cases, Pediatrics, as a part of the same area of interest. Her Internal medicine study combines topics in areas such as Gastroenterology, Oncology and Reverse-transcriptase inhibitor. Her Drug resistance research includes elements of Resistance mutation, Reverse transcriptase, Integrase, Genotype and Cohort.
Her primary scientific interests are in Internal medicine, Severe acute respiratory syndrome coronavirus 2, Cohort study, Viral load and Coronavirus disease 2019. Her Internal medicine research is multidisciplinary, relying on both Gastroenterology and Dolutegravir. Her Severe acute respiratory syndrome coronavirus 2 study incorporates themes from Virology, Whole genome sequencing, Lineage specific, Antibody and Spike Protein.
Her study in Virology is interdisciplinary in nature, drawing from both Epitope, Antibody response and Peptide sequence. Her research integrates issues of Population level, Genotype and Antiretroviral therapy in her study of Viral load. Her work on Viremia as part of general Immunology research is frequently linked to Alpha interferon, thereby connecting diverse disciplines of science.
Sabine Yerly mainly focuses on Antibody, Severe acute respiratory syndrome coronavirus 2, Viral load, Virology and Coronavirus disease 2019. Her Severe acute respiratory syndrome coronavirus 2 research is multidisciplinary, incorporating perspectives in Humoral immunity, Cohort and Population study. As part of her Immunology and Genetics and Viral load studies, she is studying Viral load.
Her Viremia study in the realm of Immunology interacts with subjects such as Alpha interferon. Her work in the fields of Virology, such as Virus, intersects with other areas such as Protein Array Analysis. Her Coronavirus disease 2019 research includes themes of Gastroenterology, Longitudinal study and Serology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Silvia Stringhini;Silvia Stringhini;Silvia Stringhini;Ania Wisniak;Giovanni Piumatti;Giovanni Piumatti;Andrew S Azman;Andrew S Azman.
The Lancet (2020)
Transmission of antiretroviral-drug-resistant HIV-1 variants
S Yerly;L Kaiser;E Race;J P Bru.
The Lancet (1999)
Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management
Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö.
The Journal of Infectious Diseases (2005)
Cohort profile: the Swiss HIV Cohort study
Franziska Schoeni-Affolter;Bruno Ledergerber;Martin Rickenbach;Christoph Rudin.
International Journal of Epidemiology (2010)
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan
Victor DeGruttola;Lynn Dix;Richard D'Aquila;Dan Holder.
Antiviral Therapy (2000)
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
Selidji T Agnandji;Angela Huttner;Madeleine E Zinser;Patricia Njuguna.
The New England Journal of Medicine (2016)
Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen
Nicolas Sachsenberg;Alan S. Perelson;Sabine Yerly;Gérard A. Schockmel.
Journal of Experimental Medicine (1998)
A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection
Sabine Kinloch De Loës;Bernard J. Hirschel;Bruno Hoen;David A. Cooper.
The New England Journal of Medicine (1995)
Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.
Ravindra K Gupta;Andrew Hill;Anthony W Sawyer;Alessandro Cozzi-Lepri.
Lancet Infectious Diseases (2009)
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.
S Yerly;S Vora;P Rizzardi;J P Chave.
AIDS (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Zurich
University of Basel
University of Zurich
University of Lausanne
Universita della Svizzera Italiana
Hôpitaux Universitaires de Genève
University Hospital of Basel
University of St. Gallen
Geneva College
University of Bern
University of Edinburgh
Columbia University
University of Georgia
University of Calgary
Lawrence Berkeley National Laboratory
University of Illinois at Chicago
Deakin University
Durham University
Friedrich Schiller University Jena
Norwegian Polar Institute
National Institute for Environmental Studies
University of British Columbia
Washington University in St. Louis
National University of Singapore
Saint Mary's University
University of Massachusetts Amherst